Ebola virus disease
Conditions
Sponsors
National Center for Global Health and Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient who met all of the following criteria is enrolled in the study. 1. Among those who met either of the following criteria I or II, the Case Management Committee evaluates the appropriateness of the subject for this study. I. Patient who was definitively diagnosed with Ebola virus disease based on the positive PCR test. II. Patient who developed symptoms that are consistent with Ebola virus disease within a few days prior to the onset, and who met one of the following 3 conditions. A. Patient who previously touched the body fluids from an Ebola virus-infected patient or a suspected patient with Ebola virus disease. B. Patient who previously touched or possibly touched any Ebola virus-infected animals, their bodies, or their flesh meat. C. Patient with a travel history to the area where Ebola virus disease is present within 21 days prior to the onset of illness. 2. Principally, male and female aged 20 years or older. However, even minors are allowed to participate in the study only when his/her doctor understands the significance of the treatment provided in this study. 3. Patient aged 20 years or older who submitted informed consent. Proxy consent is acceptable in case the patient is incompetent to consent to the contract. For those younger than 20 years, written consent of both the patient and his/her parent (or the replacement) is required for junior-high and high school students. For primary school child or younger, written consent of his/her parent (or the replacement) is required.
Exclusion criteria
Exclusion criteria: Patient who was considered as inadequate for this study by the Case Management Committee.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient survival at the end of study or at discontinuation | — |
Countries
Japan
Contacts
Public ContactYasuyuki Kato
National Center for Global Health and Medicine Division of Preparedness and Emerging Infections, Disease Control and Prevention Center
Outcome results
None listed